865869-26-7Relevant articles and documents
Copper-catalyzed cross-coupling of vinyliodonium salts and diboron reagents to generate alkenyl boronic esters
Bao, Robert Li-Yuan,Gan, Shaoyan,Shi, Lei,Zhu, Dan
supporting information, p. 5567 - 5570 (2020/08/21)
An efficient approach for the synthesis of alkenyl boronic esters through the copper-catalyzed cross-coupling of vinyliodonium salts and diboron reagents is reported. This method is distinguished by its mild conditions and short reaction time of less than
INHIBITORS OF HEPATITIS C VIRUS POLYMERASE
-
, (2012/06/30)
The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.
QUINAZOLINONE DERIVATIVES AS VIRAL POLYMERASE INHIBITORS
-
, (2011/04/19)
Compounds of formula I: (I) wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
SUBSTITUTED FUROPYRIMIDINES AND USE THEREOF
-
Page/Page column 27, (2011/07/29)
The present application relates to novel substituted furopyrimidine derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular diseases.
4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS
-
Page/Page column 65, (2010/02/14)
Novel antiviral compounds of Formula (I) : wherein: A represents hydroxy; R1 represents aryl, heteroaryl bonded through a ring carbon atom, or heterocyclyl bonded through a ring carbon atom, C1-6alkyl or -C5-9cycloalkyl, each of which may be optionally su